Caxton Associates (New York)’s Zions Bancorporation ZION Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-7,011
Closed -$312K – 568
2019
Q3
$312K Buy
+7,011
New +$303K 0.06% 248
2019
Q1
– Sell
-9,670
Closed -$394K – 507
2018
Q4
$394K Buy
+9,670
New +$451K 0.06% 139
2018
Q1
– Sell
-250,000
Closed -$12.7M – 459
2017
Q4
$12.7M Sell
250,000
-10,000
-4% -$479K 0.63% 51
2017
Q3
$12.3M Buy
260,000
+110,000
+73% +$4.89M 0.44% 54
2017
Q2
$6.59M Buy
+150,000
New +$6.18M 0.25% 114
2017
Q1
– Sell
-100,000
Closed -$4.3M – 464
2016
Q4
$4.3M Buy
+100,000
New +$3.68M 0.19% 99
2015
Q4
– Sell
-150,000
Closed -$4.13M – 94
2015
Q3
$4.13M Buy
150,000
+113,750
+314% +$3.37M 0.25% 52
2015
Q2
$1.15M Buy
+36,250
New +$1.07M 0.05% 114
2015
Q1
– Sell
-175,000
Closed -$4.99M – 206
2014
Q4
$4.99M Sell
175,000
-150,000
-46% -$4.23M 0.39% 53
2014
Q3
$9.45M Buy
325,000
+225,000
+225% +$6.53M 0.31% 56
2014
Q2
$2.95M Buy
+100,000
New +$2.94M 0.15% 107

Other funds holding ZION

Caxton Associates (New York)'s ZION Position: Q4 2019 in Review

Caxton Associates (New York) sold out of Zions Bancorporation (ZION) in Q4 2019, closing a stake of 7,011 shares — an estimated $312K sold.

Caxton Associates (New York) first reported a position in ZION in Q2 2014 and held it in 11 quarters. The position peaked at $12.7M in Q4 2017. 475 funds tracked by Wall St. Rank hold ZION as of Q4 2019.

  • Caxton Associates (New York) reported no remaining Zions Bancorporation position as of Q4 2019 after selling out during the quarter.
  • Caxton Associates (New York) sold 7,011 Zions Bancorporation shares in Q4 2019, an estimated $312K.
  • Caxton Associates (New York) first reported a position in Zions Bancorporation in Q2 2014 and held it in 11 quarters.
  • Caxton Associates (New York)'s Zions Bancorporation position peaked at $12.7M in Q4 2017.
  • 475 funds tracked by Wall St. Rank held Zions Bancorporation as of Q4 2019.

Based on Caxton Associates (New York)'s 13F filing for Q4 2019, filed 14 Feb 2020.